UnitedHealthcare Issues New Policy Expanding Coverage of Precision Oncology Diagnostics

UnitedHealthcare has issued a new policy providing coverage for a variety of molecular tests used to personalize the care of cancer patients.

The medical policy, effective April 1, addresses multiple cancer types and test technologies, as well as a spectrum of early- to late-stage indications and clinical applications. However, the major changes from a prior policy made effective Jan. 1 center on multi-gene sequencing tests for molecular profiling of solid tumors.